Company

Neuroglee Therapeutics, Inc.

Neuroglee Therapeutics develops digital programs and services for memory and dementia care.

About

Founded in 2020 and based in Singapore, Neuroglee Therapeutics develops digital cognitive health programs for people with dementia and their care partners. It works with healthcare organizations and offers services through a digital platform. In September 2021, it raised USD 10.000 mn in Series A funding co-led by EDBI and Openspace Ventures.

1Funding rounds

2Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in